Occipital Neuralgia Stem Cell Therapy in Istanbul, Turkey
Stem cell therapy for occipital neuralgia. MSC treatments target occipital nerve repair, reduce neuroinflammation, and modulate pain signaling for lasting relief from chronic head and neck pain.
Frequently Asked Questions About Occipital Neuralgia Stem Cell Therapy
How does stem cell therapy help occipital neuralgia?
MSCs release neurotrophic factors that support occipital nerve repair, anti-inflammatory molecules that reduce neuroinflammation, and immunomodulatory signals that help normalize aberrant pain processing in the occipital nerve distribution.
How is stem cell therapy different from nerve blocks for occipital neuralgia?
Nerve blocks provide temporary pain relief by numbing the nerve. MSC therapy aims to repair the underlying nerve damage and inflammation, potentially providing longer-lasting relief by addressing root causes rather than temporarily masking symptoms.
What results can I expect from stem cell therapy for occipital neuralgia?
Most patients experience pain reduction within 4-8 weeks, with progressive improvement over 3-6 months. Many report reduced headache frequency and intensity, decreased medication reliance, and improved quality of life.
Is stem cell therapy safe for occipital neuralgia?
MSC therapy has a strong safety profile for neurological conditions. Our Wharton's jelly-derived stem cells are immunoprivileged with minimal rejection risk. The procedure combines IV infusion with targeted delivery, both minimally invasive approaches.